15th industry stakeholder platform on research and development support

Event Human Research and development

Date

, -

Location

European Medicines Agency, Amsterdam, the Netherlands

Event summary

This is the fifteenth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addresses all areas of evidence generation along the medicine’s life-cycle and related to development support activities, such as scientific advice and qualification, as well as specifics for paediatric and orphan medicines. 

This meeting focuses on:

  • strengthening the delivery of scientific advice to efficiently support development programmes including agile scientific advice and broad scientific advice affecting multiple products
  • modernising the Qualification of Novel Methodologies framework
  • translating the experience from the piloting of the new PRIME features into optimised operations
  • feedback from the HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment
  • proposal for the pilot of a voluntary data submission framework to establish potential alternatives to animal testing in line with the 3Rs principles
  • progressing the support to paediatric developments
  • identification of product-specific bioequivalence guidelines
  • gocus group to explore opportunities for the use of Real-World Data (RWD) and the generation of Real-World Evidence (RWE)
  • strengthening support to evidence generation for combination (MD/IVD) Products

Documents

Contact point

Share this page